Follow us on
Welcome Guest! You are here: Home » Health
New antibody to fight flu pandemics, pneumonia
Saturday February 14, 2015 11:18 AM, IANS

Researchers have developed an antibody which boosts the survival chances of patients suffering from influenza and pneumonia.

Proven effective in lab tests, the antibody is now being made suitable for use among humans. The scientists are also using the new antibody to develop a diagnostic kit which can help doctors accurately track the recovery progress of flu and pneumonia patients.

"While it will take up to eight years to develop the antibody into a useable treatment for human patients, we are currently developing a diagnostic kit which should be commercialised in about three years," said Andrew Tan, associate professor at the Nanyang Technological University in Singapore.

Professor Tan, who led an interdisciplinary team of scientists from Singapore, developed the new antibody.

The new antibody works by blocking a protein called ANGPTL4, which was found to be in high concentration in the tissue samples taken from patients suffering from pneumonia.

"When the antibody we developed was given to mice suffering from pneumonia and influenza, these mice recovered much faster than the other mice, which did not receive the antibodies," Tan said.

The patent-pending antibody has generated much interest globally. Two biotech multinational corporations, Britain-based Abcam and US-based Adipogen International, have won the rights to licence the antibody.

The two multinational companies will produce the antibody for sale to global organisations conducting research in vaccine and drug development, the researchers said.

The World Health Organisation estimated that influenza results in about three to five million cases of severe illness worldwide each year, with about 250,000 to 500,000 deaths annually.

Pneumonia is the leading cause of death in children worldwide, accounting for 15 percent of all child deaths under five years of age, the study added.

The study appeared in the journal Cell Reports.




Share this page
 Comments
Note: By posting your comments here you agree to the terms and conditions of www.ummid.com
comments powered by Disqus
Advertisement
| Quick links
About ummid.com
Contact us
Feedback
Subscribe to: RSS » Facebook » Twitter » Newsletter
Ummid.com: Disclaimer | Terms of Use | Advertise with us | Link Exchange
Ummid.com is part of the Awaz Multimedia & Publications providing World News, News Analysis and Feature Articles on Education, Health. Politics, Technology, Sports, Entertainment, Industry etc. The articles or the views displayed on this website are for public information and in no way describe the editorial views. The users are entitled to use this site subject to the terms and conditions mentioned.
© 2012 Awaz Multimedia & Publications. All rights reserved.